JPRN-UMIN000006669已完成未知
Discontinuation of adalimumab without functional and structural damage progression after attaining sustained remission in patients with rheumatoid arthritis: An observational study - HUMIRA discontinuation withOut functional and radiographic damage progressioN follOwing sustained Remission in rheumatoid arthritis (HONOR study)
niversity of Occupational and Environmental Health, Japan0 个研究点目标入组 50 人开始时间: 2011年11月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Use of glucocorticoids for 24 weeks prior to discontinuation of adalimumab, 2) use of NSAIDs for 24 weeks prior to discontinuation of adalimumab, 3) severe infection, 4) active tuberculosis, 5) demyelinating disease (multiple sclerosis), 6) congestive heart failure, 7) Patient who is lactating, pregnant, possibly pregnant or do not agree with anti-conception during the trial and 6 months after the last administration of adalimumab, 8) patients who are inadequate to enter this trial due to the other reasons as judged by investigators
研究者
相似试验
已完成
不适用
Discontinuation of infliximab therapy after acquisition of low disease activity by infliximab in rheumatoid arthritis study: RRR (remission induction by remicade) studyrheumatoid arthritisJPRN-UMIN000002110niversity of Occupational & Environmental Health, Japan100
招募中
不适用
Discontinuation of biological agents without functional and structural damage progression after attaining sustained remission in patients with rheumatoid arthritisRheumatoid ArthritisJPRN-UMIN000022596Department of Hematology and Rheumatology, Kinki University School of Medicine110
招募中
4 期
Prospective follow-up study of adalimumab treatment in ankylosing spondylitis: efficacy with focus on uveitisAnkylosing spondylitisBechterew's disease10023213NL-OMON30515Vrije Universiteit Medisch Centrum100
已完成
不适用
Clinical Effectiveness of Adalimumab (Exemptiaâ?¢) in patients suffering from symptomatic Ankylosing Spondylitis (AS) under supervised standard rheumatology careCTRI/2018/02/012018CENTER FOR RHEUMATIC DISEASES50
尚未招募
2 期
The effect of Adalimumab in the treatment of patients with chronic schizophreniaSchizophrenia.SchizophreniaIRCT20090117001556N126Tehran University of Medical Sciences50